A new tooth-regrowing drug has finally entered human trials after months of waiting and promising clinical trials on mice and ...

India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...

Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...

Novo Nordisk shareholders were seeking on Friday to find out why such a high number of patients in the late-stage trial of ...

Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its ...

Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

GSK said on Friday that adding its cancer drug Jemperli to both standard-of-care chemotherapy and Zejula as a maintenance ...

New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...

Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for ...

The lack of success in drug trials has a negative impact on the Foster City company's China strategy and stock price. Apollomics Inc., a late-stage clinical biopharmaceutical company, said its ...